https://hal-univ-lyon1.archives-ouvertes.fr/hal-02046812
Contributor : Christelle Cheval
<>
Submitted on : Friday, February 22, 2019 - 7:05:02 PM
Last modification on : Monday, May 27, 2019 - 10:48:19 AM
Sylvain Goutelle, Laurent Bourguignon, P. Maire, R. W. Jelliffe, M. Neely. The Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy. Current Pharmaceutical Design, 2014, 20, pp.6191-6206. ⟨hal-02046812⟩
